Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial. File Photo by Brian Kersey/UPI A powerful new ...
Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...
Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...
Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Cancer death rates in the UK have fallen to a historic new low, Cancer Research UK has announced. The charity, which analysed ...
A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results